Literature DB >> 8017889

The virology of demyelinating diseases.

R T Johnson1.   

Abstract

Infectious agents have been postulated as causes of multiple sclerosis for over a century. The possible role of a virus or viruses is supported by data that (1) a childhood exposure is involved and "viral" infections may precipitate exacerbations of disease, (2) experimental infections in animals and natural infections in humans can cause diseases with long incubation periods, remitting and relapsing courses, and demyelination, and (3) patients with multiple sclerosis have abnormal immune responses to viruses. The pathogenesis of three human demyelinating diseases of known viral etiology is discussed. In progressive multifocal leukoencephalopathy, a papovavirus selectively infects oligodendrocytes and causes focal areas of demyelination. In postmeasles encephalomyelitis, the virus is lymphotrophic and disrupts immune regulation that can result in an autoimmune perivenular demyelinating illness without evidence of infection of the central nervous system. In human immunodeficiency virus-encephalopathy and myelopathy virus is present in macrophages and microglia and the myelin abnormalities apparently are caused by soluble factors such as viral proteins, cytokines, or neurotoxins. These findings may have implications on how, when, and where to seek viruses in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017889      PMCID: PMC7159614          DOI: 10.1002/ana.410360715

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  75 in total

1.  Interferon gamma in acute and subacute encephalitis.

Authors:  P Lebon; B Boutin; O Dulac; G Ponsot; M Arthuis
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

2.  Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation.

Authors:  L P Weiner; O Narayan; J B Penney; R M Herndon; E R Feringa; W W Tourtellotte; R T Johnson
Journal:  Arch Neurol       Date:  1973-07

3.  Editorial: Koch's postulates and slow infections of the nervous system.

Authors:  R T Johnson; C J Gibbs
Journal:  Arch Neurol       Date:  1974-01

4.  Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus.

Authors:  O Narayan; J B Penney; R T Johnson; R M Herndon; L P Weiner
Journal:  N Engl J Med       Date:  1973-12-13       Impact factor: 91.245

5.  HTLV-III infection in brains of children and adults with AIDS encephalopathy.

Authors:  G M Shaw; M E Harper; B H Hahn; L G Epstein; D C Gajdusek; R W Price; B A Navia; C K Petito; C J O'Hara; J E Groopman
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

6.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.

Authors:  S L Wesselingh; C Power; J D Glass; W R Tyor; J C McArthur; J M Farber; J W Griffin; D E Griffin
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

7.  Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections.

Authors:  M Graves; D E Griffin; R T Johnson; R L Hirsch; I L de Soriano; S Roedenbeck; A Vaisberg
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

8.  Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease.

Authors:  D E Griffin; B J Ward; E Juaregui; R T Johnson; A Vaisberg
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

9.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

10.  Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon.

Authors:  P G Kennedy; O Narayan; Z Ghotbi; J Hopkins; H E Gendelman; J E Clements
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  31 in total

1.  CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.

Authors:  K L Neville; M C Dal Canto; J A Bluestone; S D Miller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Positive PCR for enterovirus in the cerebrospinal fluid of a child with acute disseminated encephalomyelitis.

Authors:  Paolo Mariotti; Anna Paola Batocchi; Cesare Colosimo; Paola Cattani; Maria Chiara Stefanini; Francesca Colitto; Pietro Tonali; Francesco Guzzetta
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

3.  The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson.

Authors:  Eric J Kildebeck; Ram Narayan; Avindra Nath; Howard Weiner; Shin Beh; Peter A Calabresi; Lawrence Steinman; Eugene O Major; Teresa C Frohman; Elliot M Frohman
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

4.  Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

Authors:  Angel Arévalo-Martín; José Miguel Vela; Eduardo Molina-Holgado; José Borrell; Carmen Guaza
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

5.  Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms.

Authors:  M Mayne; C Cheadle; S S Soldan; C Cermelli; Y Yamano; N Akhyani; J E Nagel; D D Taub; K G Becker; S Jacobson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Epstein-Barr Virus and MS:Causality or Association?

Authors:  Sk Ludwin; S Jacobson
Journal:  Int MS J       Date:  2011-05

7.  Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line.

Authors:  P J Koetters; L Hassanieh; S A Stohlman; T Gallagher; M M Lai
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

Review 8.  Axonal pathology and demyelination in viral models of multiple sclerosis.

Authors:  Jane E Libbey; Thomas E Lane; Robert S Fujinami
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

9.  A mechanism of virus-induced demyelination.

Authors:  Jayasri Das Sarma
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-21

Review 10.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.